BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In April 2024, Penumbra, Inc, a global healthcare company, announced FDA clearance and the launch of Lightning Flash 2.0, an advanced computer-assisted vacuum thrombectomy (CAVT) system. This system is designed to remove venous thrombus and treat pulmonary emboli (PE) with enhanced speed and sensitivity, utilizing Lightning Flash algorithms and novel catheter technology to navigate complex anatomy and potentially minimize blood loss.
• In February 2024, CERENOVUS, Inc., part of Johnson & Johnson MedTech, launched the CEREGLIDE 71 Intermediate Catheter, a next-generation device designed for the revascularization of acute ischemic stroke patients. This catheter, featuring TruCourse technology, is optimized for effective direct aspiration and delivery of compatible stent retrievers like the EMBOTRAP III Revascularization Device, enhancing the CERENOVUS STROKE SOLUTIONS portfolio.
• In July 2021, Surmodics, Inc., a company involved in surface modification technologies for intravascular medical devices, acquired Vetex Medical Limited, an Ireland-based company specializing in venous clot removal solutions. This acquisition enhanced Surmodics’ thrombectomy portfolio, adding the ReVene Thrombectomy Catheter, which is USFDA 510(k)-cleared.
• In March 2022, Medtronic Private Limited, a subsidiary of Medtronic plc, a healthcare technology company, launched India's first dedicated registry for collecting real-world data on the use of revascularization devices in acute ischemic stroke (AIS) patients. Named the Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with Neurothrombectomy Devices in India (PRAAN), this initiative aims to evaluate clinical outcomes associated with Medtronic's revascularization devices post-market.